Phoenix Wound Matrix is a 3D electrospun synthetic polymer matrix, an FDA 510K cleared medical device.
INTENDED USES: Intended for use in the management of wounds. Wound types include: Partial and full-thickness
wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh's surgery, post laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second degree burns, skin tears) and draining wounds.
CLAIMED BENEFITS: Microporous synthetic polymer scaffold for regenerative wound healing. Fully resorbs within 7-14 days. Sustained release of glycolic, caproic and lactic acids. Encourages a healthy microenvironment. Acceleration of stalled wound healing confirmed. Aims for an average <8 weeks to closure, with 2 or fewer applications.
OPTIONS: Per Square Centimeter
Wound Reference does not produce, market, re-sell or distribute health care goods or services consumed by, or used on, patients.
